April 17, 2016
Sage Therapeutics
Sage Therapeutics Expands Scientific, Clinical and Burden of Illness Data for SAGE-547 in SRSE and Essential Tremor at the 2016 American Academy of Neurology Annual Meeting
April 15, 2016
Blueprint Medicines
Blueprint Medicines Appoints Lynn Seely, M.D. to Board of Directors
April 14, 2016
Voyager Therapeutics
Voyager Therapeutics to Host R&D Day and Webcast on April 29, 2016
April 13, 2016
KALA BIO
Kala Pharmaceuticals Announces Closing of $68 Million Series C Financing